A Comparison of Prolonged Exposure Therapy, Pharmacotherapy, and Their Combination for PTSD

Key facts

Sponsor

University of Pennsylvania

Intervention

Prolonged Exposure Therapy(behavioral)

Enrollment

302 target

Eligibility

18-75 years · All sexes

Timeline

2022 – 2026

Study locations (7)

• Birmingham VA Healthcare System, Birmingham, Alabama, United States
• VA Palo Alto Healthcare System, Menlo Park, California, United States
• VA San Diego Healthcare System, San Diego, California, United States
• Coatesville VA Medicial Center, Coatesville, Pennsylvania, United States
• Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania, United States
• VA North Texas Healthcare System, Dallas, Texas, United States
• Milwaukee VA Medical Center, Milwaukee, Wisconsin, United States

Collaborators

Patient-Centered Outcomes Research Institute · Corporal Michael J. Crescenz VA Medical Center · Coatesville VA Medical Center · Milwaukee VA Medical Center · North Texas Veterans Healthcare System · San Diego Veterans Healthcare System · VA Palo Alto Health Care System · Birmingham VA Health Care System

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Best vitelliform macular dystrophy

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT07171554
  Evaluation of a Diagnostic Test to Identify the Best Drugs for Treatment of Metastatic Colorectal Cancer
  Oncosyne AS
• RECRUITINGNANCT07234409
  Clinical Trial Addressing the Best Surgical Approach for Partial Nephrectomy With Single Port Robotic System in the Management of Localized Renal Cell Carcinoma
  Niguarda Hospital
• RECRUITINGNANCT07281092
  Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)
  Seattle Children's Hospital
• RECRUITINGPHASE1, PHASE2NCT07185256
  Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)
  Opus Genetics, Inc
• RECRUITINGNCT06805474
  A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT
  Nanoscope Therapeutics Inc.
• RECRUITINGNANCT06899399
  Efficacy and Safety Study of Endovascular Treatment of Asymptomatic Carotid Artery Stenosis
  Beijing Tiantan Hospital
• ACTIVE NOT RECRUITINGNANCT05802940
  Low Dose Aspirin Alerts in High-Risk Pregnancies
  Geisinger Clinic
• RECRUITINGNANCT05737407
  Lung Ultrasound Guided Choice of Best Positive End-Expiratory Pressure in Neonatal Anesthesia
  Vittore Buzzi Children's Hospital

See all trials for Best vitelliform macular dystrophy →